SIRION Biotech licenses its LentiBOOST® transduction technology to Cellectis
Munich, Germany and Cambridge, Mass., January 7, 2021–Through this license agreement, SIRION...
Munich, Germany and Cambridge, Mass., January 7, 2021–Through this license agreement, SIRION...
| Source:Mustang Bio, Inc.,globenewswire.com
WORCESTER, Mass. and...
BOSTON and LONDON and MARTINSRIED, Germany, Dec. 14, 2018 (GLOBE NEWSWIRE) — Orchard Therapeutics...
Munich, Germany and Cambridge, Mass., January 7, 2021–Through this license agreement, SIRION...
| Source:Mustang Bio, Inc.,globenewswire.com
WORCESTER, Mass. and...
BOSTON and LONDON and MARTINSRIED, Germany, Dec. 14, 2018 (GLOBE NEWSWIRE) — Orchard Therapeutics...
Munich, Germany and Cambridge, Mass., January 7, 2021–Through this license agreement, SIRION...
| Source:Mustang Bio, Inc.,globenewswire.com
WORCESTER, Mass. and...
BOSTON and LONDON and MARTINSRIED, Germany, Dec. 14, 2018 (GLOBE NEWSWIRE) — Orchard Therapeutics...
Munich, Germany and Cambridge, Mass., January 7, 2021–Through this license agreement, SIRION...
| Source:Mustang Bio, Inc.,globenewswire.com
WORCESTER, Mass. and...
BOSTON and LONDON and MARTINSRIED, Germany, Dec. 14, 2018 (GLOBE NEWSWIRE) — Orchard Therapeutics...
Munich, Germany and Cambridge, Mass., January 7, 2021–Through this license agreement, SIRION...
| Source:Mustang Bio, Inc.,globenewswire.com
WORCESTER, Mass. and...
BOSTON and LONDON and MARTINSRIED, Germany, Dec. 14, 2018 (GLOBE NEWSWIRE) — Orchard Therapeutics...